Skip to main content
. 2024 Aug 15;16(8):4020–4031. doi: 10.62347/UAGF1249

Table 1.

Characteristics of study participants

Category Group 1 Group 2 p-value 95% CI
Hysteroscopic adhesiolysis Yes Yes - -
ADMSC treatment No Yes - -
Sample size (n) 20 21 - -
Age (years) 37.9 ± 5.9 40.0 ± 4.7 0.2160 -1.277 to 5.477
BMI (kg/m2) 26.2 ± 3.2 24.8 ± 2.4 0.1135 -3.175 to 0.3520
Infertility duration (years) 4.6 ± 3.2 3.5 ± 3.2 0.2500 -3.152 to 0.8448
Previous IVF cycles with implantation failure (n)a 0.6 ± 0.8 0.8 ± 0.9 0.4494 -0.3451 to 0.7642
No. of patients with canceled ET 11 9 - -
No. of patients with at least one failed cycle 9 12 - -
AS classification at the time of enrollment
Removed IUA at the time of ADMSC application Not applicable 33.3% (7/21)
    Stage I, mild 55.0% (11/20) 42.9% (9/21)
    Stage II, moderate 30.0% (6/20) 14.3% (3/21)
    Stage III, severe 15.0% (3/20) 9.5% (2/21)

Abbreviations: 95% CI: 95% confidence interval; ADMSC: adipose-derived mesenchymal stem cells; AS: Asherman’s syndrome; BMI: Body-Mass Index; IVF: in vitro fertilization; ET: embryo transfer; IUA: intrauterine adhesions. Values are percentage (frequency) or average ± standard deviation. P-value was calculated using an unpaired t-test.

a

The mean of previous IVF cycles with implantation failure is below one as for some patients with poor quality endometrium; their embryo transfer was canceled.

AS classification according to the American Fertility Society 1988 at the time of enrollment [17].